101 |
|
Polyamines are sometimes, but not always, fully protonated at physiological pH
|
Blagbrough, I. S
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
102 |
|
Prediction of hydrogen bond donor ability using new quantum chemical parameters
|
Dearden, J. C
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
103 |
|
Design and synthesis of benzopyrano[4,3-c]quinolines as topoisomerase inhibitors
|
Hutton, S. M
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
104 |
|
An investigation into the use of PVC/poloxamer blends as potential biocompatible materials
|
Kerai, R. S
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
105 |
|
Measuring log P using liposomes; a possible tool to study drug-membrane interactions
|
Avdeef, A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
106 |
|
Evaluation of cryptolepine and some analogues as leads to selective antimalarial agents
|
Wright, C. W
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
107 |
|
Evaluation of Glycyrrhiza glabra used in the treatment of psoriasis
|
Taylor, E. J
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
108 |
|
Design and synthesis of benzo[c]phenanthridine analogues as topoisomerase inhibitors
|
Kerry, M. A
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
109 |
|
The effects of emulsifier and drug (chlorhexidine) concentrations on themechanical and viscoelastic properties of creams
|
Brown, A. F
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|
110 |
|
Behaviour of oils in non-ionic oil-in-water microemulsions
|
Warisnoicharoen, W
|
Pharmaceutical Society of Great Britain
|
1980
|
|
|